Results for tag: "Sickle Cell Disease"

Sickle Cell Disease (SCD) is a group of inherited red blood cell disorders caused by a genetic mutation in the hemoglobin gene. It is characterized by red blood cells that are shaped like a sickle, or crescent, which can cause blockages in small blood vessels. This can lead to a wide range of symptoms, including anemia, pain, organ damage, and stroke. SCD is most common among people of African, Mediterranean, and Indian descent, and is estimated to affect millions of people worldwide. Treatment for SCD is focused on managing symptoms and preventing complications. This includes medications to reduce pain, antibiotics to prevent infections, and blood transfusions to reduce the risk of stroke. In some cases, stem cell transplants may be used to replace the defective hemoglobin gene. The SCD market is a subset of the larger hematology market, which includes treatments for a variety of blood disorders. Companies in this market include Novartis, GlaxoSmithKline, Pfizer, and Sanofi. Other companies, such as Celgene and Gilead Sciences, are also involved in the development of treatments for SCD. Show Less Read more